Healthcare Business

Why One Top Drug Stock Could Have Nearly 30% Upside

Mallinckrodt PLC (NYSE: MNK) has been a prominent player in the health care industry and while most analysts are taking a middle-of-the-road approach to the company, one has come out ...
Read Full Story »

Canaccord Genuity’s Top Biopharma Catalysts Coming This Quarter

Companies in the health care sector face great risk and great reward every time they make an announcement. Drug candidates passing clinical trials, gaining regulatory approval or being canceled can ...
Read Full Story »

Seattle Genetics Dips Despite FDA Win

Seattle Genetics Inc. (NASDAQ: SGEN) shares dipped on Monday following an update from the U.S. Food and Drug Administration (FDA). Essentially, the FDA granted Breakthrough Therapy Designation to Adcetris (brentuximab ...
Read Full Story »

Why Arena Pharma Is Winning Big With Its New Collaboration

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) shares jumped early on Thursday after the company announced a new global license agreement with United Therapeutics Corp. (NASDAQ: UTHR). The goal of this collaboration ...
Read Full Story »

Synthorx Gears Up for IPO

Synthorx has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, although the ...
Read Full Story »

Short Sellers Raise the Stakes in Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Moderna Gears Up for IPO

Moderna has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, although the ...
Read Full Story »

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

With just over six weeks left in what has been a very volatile 2018, many investors are wondering which direction the market will take now that Democrats are taking over ...
Read Full Story »

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The treatment of erectile dysfunction (ED) has helped literally tens of millions of men in America alone. The number of drugs treating ED has grown substantially over the years, and ...
Read Full Story »

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Nektar Therapeutics (NASDAQ: NKTR) shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer Inc. (NYSE: PFE) to evaluate several combination regimens in multiple cancer ...
Read Full Story »

Eli Lilly Dips Despite Solid Q3 Results

Eli Lilly and Co. (NYSE: LLY) released its third-quarter financial results before the markets opened on Tuesday. The pharma giant said that it had $1.39 in earnings per share (EPS) ...
Read Full Story »

Why Regulus Therapeutics Is Booming

Regulus Therapeutics Inc. (NASDAQ: RGLS) shares shot up on Tuesday after the company announced that it had amended and restructured its collaboration and license agreement with Sanofi. Under the terms ...
Read Full Story »

CVS Earnings, Merger With Aetna Look Good to Investors

CVS Health Corp. (NYSE: CVS) reported third-quarter results before markets opened Tuesday. The pharmacy retail operator posted quarterly adjusted diluted earnings per share (EPS) of $1.73 on revenues of $47.3 ...
Read Full Story »

What Drove Mylan Earnings in Q3

When Mylan N.V. (NASDAQ: MYL) reported its most recent quarterly results after the markets closed on Monday, the company said that it had $1.25 in earnings per share (EPS) and ...
Read Full Story »

Vapotherm Gears Up for IPO

Vapotherm has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. The company intends to price its 4.0 million shares in ...
Read Full Story »